Brief: Dermata Therapeutics Inc Says As Of March 31, 2023, Dermata Had $8.8 Million In Cash And Cash Equivalents
May 11 (Reuters) - Dermata Therapeutics Inc DRMA.O :
* DERMATA THERAPEUTICS INC - AS OF MARCH 31, 2023, DERMATA
HAD
$8.8 MILLION IN CASH AND CASH EQUIVALENTS
Further company coverage: DRMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dermata Therapeutics
See all newsNASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview